Uppsala Reports editor
@UMCGlobalSafety
Medical devices are everywhere, but monitoring their safety is complex. Omar Aimer discusses the unique challenges of device pharmacovigilance and what needs to change.
From bandages to MRI machines, medical devices touch all our lives, but monitoring their safety is far more complex than for medicines and vaccines. Beyond clinical risks, devices face technological threats from cybersecurity vulnerabilities to outdated software that can leave patients vulnerable.
In this two-part episode of Drug Safety Matters, host Alexandra Coutinho speaks with Omar Aimer, president of ISoP and former co-lead of the Medical Device Special Interest Group. They explore what defines a medical device, why current surveillance falls short, the unique challenges of reporting adverse events, and how global initiatives are working to strengthen safety monitoring standards and protect patients.
Subscribe by visiting the Drug Safety Matters website.
Uppsala Reports editor
@UMCGlobalSafety
Patient engagement was a hot topic at the fireside chat held during this year’s ISoP mid-year symposium.
24 June 2025
Over 500 attendees from 80+ countries met in Cairo at ISoP 2025, reflecting on pharmacovigilance progress and shaping strategies for its future.
10 December 2025
Pharmacovigilance has come a long way in helping us link medicines to their side-effects; with the help of pharmacogenomics it can go even further.
05 February 2025